πŸ‡ΊπŸ‡Έ FDA
Patent

US 9126926

Oligomer-anticholinergic agent conjugates

granted A61KA61K47/60A61P

Quick answer

US patent 9126926 (Oligomer-anticholinergic agent conjugates) held by Nektar Therapeutics expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/60, A61P, A61P13/00, A61P13/06